SHANGHAI FOSUN PHARMACEUTICAL (GROUP) financial statements, including revenue, expenses, profit, and loss

The total revenue of 600196 for the last quarter is 10.06 B CNY, and it's 5.28% lower compared to the previous quarter. The net income of Q1 24 is 609.73 M CNY.